Home › Meningioma › Florida › Miami
Meningioma clinical trials in Miami, FL
7 studies for Meningioma are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
RecruitingPhase 2
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
RecruitingPhase 2
- University of Miami, Miami
- Baptist Health Medical Group Oncology, Miami
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
RecruitingPhase 2
- Baptist Health Miami Cancer Institute, Miami
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
RecruitingPhase 2
- University of Miami, Miami
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
RecruitingObservational study
- Miami Cancer Institute, Baptist Health South Florida, Miami
Cabozantinib for Patients With Recurrent or Progressive Meningioma
RecruitingPhase 2
- Miami Cancer Institute at Baptist Health, Inc., Miami
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
RecruitingPhase 1/2
- Biogenix Molecular, Miami
Meningioma trials in other cities
- New York City, NY8 studies
- Boston, MA6 studies
- Columbus, OH6 studies
- San Francisco, CA5 studies
- San Diego, CA5 studies
- Atlanta, GA5 studies
- Jacksonville, FL5 studies
- Houston, TX4 studies
- Arlington, VA4 studies
- Phoenix, AZ4 studies
- Detroit, MI4 studies
- Durham, NC3 studies
Other studies in Miami
- Breast Cancer42 studies
- Cancer (all types)36 studies
- Non-Small Cell Lung Cancer31 studies
- Prostate Cancer27 studies
- Obesity27 studies
- Acute Myeloid Leukemia24 studies
- Metastatic Cancer24 studies
- Ovarian Cancer23 studies
- Overweight23 studies
- Multiple Myeloma21 studies
- Ulcerative Colitis21 studies
- Alzheimer's Disease20 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.